54 related articles for article (PubMed ID: 12910511)
1. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.
Ashikaga T; Krag DN; Land SR; Julian TB; Anderson SJ; Brown AM; Skelly JM; Harlow SP; Weaver DL; Mamounas EP; Costantino JP; Wolmark N;
J Surg Oncol; 2010 Aug; 102(2):111-8. PubMed ID: 20648579
[TBL] [Abstract][Full Text] [Related]
2. Persistent arm pain is distinct from persistent breast pain following breast cancer surgery.
Langford DJ; Paul SM; West C; Abrams G; Elboim C; Levine JD; Hamolsky D; Luce JA; Kober KM; Neuhaus JM; Cooper BA; Aouizerat BE; Miaskowski C
J Pain; 2014 Dec; 15(12):1238-47. PubMed ID: 25439319
[TBL] [Abstract][Full Text] [Related]
3. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
[TBL] [Abstract][Full Text] [Related]
4. Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates.
Bae SJ; Kook Y; Jang JS; Baek SH; Moon S; Kim JH; Lee SE; Kim MJ; Ahn SG; Jeong J
Breast Cancer Res; 2024 Apr; 26(1):65. PubMed ID: 38609935
[TBL] [Abstract][Full Text] [Related]
5. Changes in lymph node surgery in breast cancer and preoperative drug prescription analysis for postoperative pain management: A retrospective, cross-sectional study.
Kang ES; Lim YC; Jang BH; Lee YJ; Ha IH; Lee YS
PLoS One; 2024; 19(4):e0298270. PubMed ID: 38574043
[TBL] [Abstract][Full Text] [Related]
6. Measuring upper limb function and patient reported outcomes after major breast cancer surgery: a pilot study in an Asian cohort.
Chan KS; Zeng D; Leung JHT; Ooi BSY; Kong KT; Yeo YH; Goo JTT; Chia CLK
BMC Surg; 2020 May; 20(1):108. PubMed ID: 32430021
[TBL] [Abstract][Full Text] [Related]
7. A quantitative comparison of arm activity between survivors of breast cancer and healthy controls: use of accelerometry.
Fisher MI; Davies CC; Uhl TL
Support Care Cancer; 2020 Nov; 28(11):5307-5313. PubMed ID: 32112354
[TBL] [Abstract][Full Text] [Related]
8. EduCan trial: study protocol for a randomised controlled trial on the effectiveness of pain neuroscience education after breast cancer surgery on pain, physical, emotional and work-related functioning.
De Groef A; Devoogdt N; Van der Gucht E; Dams L; Bernar K; Godderis L; Morlion B; Moloney N; Smeets A; Van Wilgen P; Meeus M
BMJ Open; 2019 Jan; 9(1):e025742. PubMed ID: 30612114
[TBL] [Abstract][Full Text] [Related]
9. A Scoring System to Predict Arm Lymphedema Risk for Individual Chinese Breast Cancer Patients.
Wang L; Li HP; Liu AN; Wang DB; Yang YJ; Duan YQ; Zhang QN
Breast Care (Basel); 2016 Feb; 11(1):52-6. PubMed ID: 27051397
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of Using Low-Cost Motion Capture for Automated Screening of Shoulder Motion Limitation after Breast Cancer Surgery.
Gritsenko V; Dailey E; Kyle N; Taylor M; Whittacre S; Swisher AK
PLoS One; 2015; 10(6):e0128809. PubMed ID: 26076031
[TBL] [Abstract][Full Text] [Related]
11. A framework for assessment in oncology rehabilitation.
Gilchrist LS; Galantino ML; Wampler M; Marchese VG; Morris GS; Ness KK
Phys Ther; 2009 Mar; 89(3):286-306. PubMed ID: 19147708
[TBL] [Abstract][Full Text] [Related]
12. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients.
Kohrt HE; Olshen RA; Bermas HR; Goodson WH; Wood DJ; Henry S; Rouse RV; Bailey L; Philben VJ; Dirbas FM; Dunn JJ; Johnson DL; Wapnir IL; Carlson RW; Stockdale FE; Hansen NM; Jeffrey SS;
BMC Cancer; 2008 Mar; 8():66. PubMed ID: 18315887
[TBL] [Abstract][Full Text] [Related]
13. Risk of decline in upper-body function and symptoms among older breast cancer patients.
Westrup JL; Lash TL; Thwin SS; Silliman RA
J Gen Intern Med; 2006 Apr; 21(4):327-33. PubMed ID: 16686807
[TBL] [Abstract][Full Text] [Related]
14. Lymphoscintigraphy and triangulated body marking for morbidity reduction during sentinel node biopsy in breast cancer.
Krynyckyi BR; Shafir MK; Kim SC; Kim DW; Travis A; Moadel RM; Kim CK
Int Semin Surg Oncol; 2005 Nov; 2():25. PubMed ID: 16277655
[TBL] [Abstract][Full Text] [Related]
15. Using the intraoperative hand held probe without lymphoscintigraphy or using only dye correlates with higher sensory morbidity following sentinel lymph node biopsy in breast cancer: a review of the literature.
Kim SC; Kim DW; Moadel RM; Kim CK; Chatterjee S; Shafir MK; Travis A; Machac J; Krynyckyi BR
World J Surg Oncol; 2005 Sep; 3():64. PubMed ID: 16194276
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy progress in surgical treatment of cancer.
Schulze T; Bembenek A; Schlag PM
Langenbecks Arch Surg; 2004 Nov; 389(6):532-50. PubMed ID: 15197548
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy.
Layeeque R; Kepple J; Henry-Tillman RS; Adkins L; Kass R; Colvert M; Gibson R; Mancino A; Korourian S; Klimberg VS
Ann Surg; 2004 Jun; 239(6):841-5; discussion 845-8. PubMed ID: 15166963
[TBL] [Abstract][Full Text] [Related]
18. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
Rietman JS; Dijkstra PU; Geertzen JH; Baas P; De Vries J; Dolsma W; Groothoff JW; Eisma WH; Hoekstra HJ
Cancer; 2003 Aug; 98(4):690-6. PubMed ID: 12910511
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
